靶点针对疾病信息39(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
INDICATI
Approved Osteosarcoma [ICD-11: 2B51]
INDICATI
Approved Prostate cancer [ICD-11: 2C82]
INDICATI
Phase 3 Bladder cancer [ICD-11: 2C94]
INDICATI
Phase 3 Malaria [ICD-11: 1F40-1F45]
INDICATI
Phase 3 Respiratory infection [ICD-11: CA07-CA4Z]
INDICATI
Phase 2 Mature B-cell lymphoma [ICD-11: 2A85]
INDICATI
Phase 2 Metastatic tumour [ICD-11: 2D50-2E2Z]
INDICATI
Phase 2 Squamous cell carcinoma [ICD-11: 2B60-2D01]
INDICATI
Phase 1/2 Mycobacterium infection [ICD-11: 1B10-1B21]
INDICATI
Phase 1 Human immunodeficiency virus disease [ICD-11: 1C60-1C62]
INDICATI
Phase 1 Influenza [ICD-11: 1E30-1E32]
INDICATI
Phase 1 Skin disease [ICD-11: EA00-EM0Z]
INDICATI
Discontinued in Phase 3 Lupus erythematosus [ICD-11: 4A40]
INDICATI
Discontinued in Phase 2 Head and neck cancer [ICD-11: 2D42]
INDICATI
Discontinued in Phase 2 Stomach cancer [ICD-11: 2B72]
INDICATI
Preclinical Fungal infection [ICD-11: 1F29-1F2F]